Perinatal outcomes in women with class IV obesity compared to women in the normal or overweight body mass index categories: A population-based cohort study in Qatar.

adverse perinatal outcomes cesarean delivery class IV obesity in pregnancy

Journal

Obesity science & practice
ISSN: 2055-2238
Titre abrégé: Obes Sci Pract
Pays: United States
ID NLM: 101675151

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 18 03 2023
revised: 04 07 2023
accepted: 07 07 2023
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 24 1 2024
Statut: epublish

Résumé

The prevalence of childhood and adult obesity is rising exponentially worldwide. Class IV obesity (body mass index, BMI ≥50 kg/m A retrospective cohort study was performed in Qatar, including women having singleton live births beyond 24 weeks of gestation, classified into two class IV obesity and normal/overweight (BMI between 18.5 and 30.0 kg/m A total of 247 women with class IV obesity were compared with 6797 normal/overweight women. Adjusted analysis showed that women with class IV obesity had 3.2 times higher odds of cesarean delivery (aOR: 3.19, CI: 2.26-4.50), 3.4 times higher odds of gestational diabetes (aOR: 3.39, CI: 2.55-4.50), 4.2 times higher odds of gestational hypertension (aOR: 4.18, CI: 2.45-7.13) and neonatal morbidity (aOR: 4.27, CI: 3.01-6.05), and 6.5 times higher odds of macrosomia (aOR 6.48, CI 4.22-9.99). Class IV obesity is associated with more adverse perinatal outcomes compared with the normal or overweight BMI categories. The study results emphasized the need for specialized antenatal obesity clinics to address the associated risks and reduce complications.

Sections du résumé

Background UNASSIGNED
The prevalence of childhood and adult obesity is rising exponentially worldwide. Class IV obesity (body mass index, BMI ≥50 kg/m
Methods UNASSIGNED
A retrospective cohort study was performed in Qatar, including women having singleton live births beyond 24 weeks of gestation, classified into two class IV obesity and normal/overweight (BMI between 18.5 and 30.0 kg/m
Results UNASSIGNED
A total of 247 women with class IV obesity were compared with 6797 normal/overweight women. Adjusted analysis showed that women with class IV obesity had 3.2 times higher odds of cesarean delivery (aOR: 3.19, CI: 2.26-4.50), 3.4 times higher odds of gestational diabetes (aOR: 3.39, CI: 2.55-4.50), 4.2 times higher odds of gestational hypertension (aOR: 4.18, CI: 2.45-7.13) and neonatal morbidity (aOR: 4.27, CI: 3.01-6.05), and 6.5 times higher odds of macrosomia (aOR 6.48, CI 4.22-9.99).
Conclusions UNASSIGNED
Class IV obesity is associated with more adverse perinatal outcomes compared with the normal or overweight BMI categories. The study results emphasized the need for specialized antenatal obesity clinics to address the associated risks and reduce complications.

Identifiants

pubmed: 38264000
doi: 10.1002/osp4.698
pii: OSP4698
pmc: PMC10804329
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e698

Informations de copyright

© 2023 The Authors. Obesity Science & Practice published by World Obesity and The Obesity Society and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Fathima Minisha (F)

Department of Obstetrics and Gynecology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Najat Khenyab (N)

Department of Obstetrics and Gynecology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Salwa Abu Yaqoub (S)

Department of Obstetrics and Gynecology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Sawsan Al Obaidly (S)

Department of Obstetrics and Gynecology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Mai AlQubaisi (M)

Department of Pediatrics and Neonatology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Husam Salama (H)

Department of Pediatrics and Neonatology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Tawa Olukade (T)

Department of Pediatrics Hamad Medical Corporation Doha Qatar.

Abdul Rouf Pallivalappil (AR)

Department of Research Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Nader Al Dewik (N)

Department of Research Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Hilal Al Rifai (H)

Department of Pediatrics and Neonatology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.
Chief Executive Officer Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Thomas Farrell (T)

Department of Obstetrics and Gynecology Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.
Department of Research Women's Wellness and Research Centre Hamad Medical Corporation Doha Qatar.

Classifications MeSH